ATE495736T1 - Verwendung von derivaten der 2-oxothiazolidin-4- corbonsäure als prä-abschuppungsmittel - Google Patents

Verwendung von derivaten der 2-oxothiazolidin-4- corbonsäure als prä-abschuppungsmittel

Info

Publication number
ATE495736T1
ATE495736T1 AT01996360T AT01996360T ATE495736T1 AT E495736 T1 ATE495736 T1 AT E495736T1 AT 01996360 T AT01996360 T AT 01996360T AT 01996360 T AT01996360 T AT 01996360T AT E495736 T1 ATE495736 T1 AT E495736T1
Authority
AT
Austria
Prior art keywords
oxothiazolidine
corbonic
depender
derivatives
acid
Prior art date
Application number
AT01996360T
Other languages
English (en)
Inventor
Jean-Baptiste Galey
Dominique Bernard
Lucie Simonetti
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE495736T1 publication Critical patent/ATE495736T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT01996360T 2000-11-17 2001-11-12 Verwendung von derivaten der 2-oxothiazolidin-4- corbonsäure als prä-abschuppungsmittel ATE495736T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0014865A FR2816838B1 (fr) 2000-11-17 2000-11-17 Utilisation de derives de l'acide 2-oxothiazolidine- 4-carboxylique comme agents prodesquamants
PCT/FR2001/003523 WO2002039976A1 (fr) 2000-11-17 2001-11-12 Utilisation de derives de l'acide 2-oxothiazolidine 4-carboxylique comme agents prodesquamants

Publications (1)

Publication Number Publication Date
ATE495736T1 true ATE495736T1 (de) 2011-02-15

Family

ID=8856595

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01996360T ATE495736T1 (de) 2000-11-17 2001-11-12 Verwendung von derivaten der 2-oxothiazolidin-4- corbonsäure als prä-abschuppungsmittel

Country Status (9)

Country Link
US (3) US20040006115A1 (de)
EP (1) EP1337234B1 (de)
JP (1) JP4072433B2 (de)
AT (1) ATE495736T1 (de)
AU (1) AU2002223058A1 (de)
DE (1) DE60143906D1 (de)
ES (1) ES2360204T3 (de)
FR (1) FR2816838B1 (de)
WO (1) WO2002039976A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040161392A1 (en) * 2003-02-19 2004-08-19 L'oreal S.A. Skin peeling composition and method
FR2888494B1 (fr) * 2005-07-13 2014-03-14 Oreal Utilisation de composes d'uree pour favoriser la desquamation
UA96283C2 (uk) * 2005-12-23 2011-10-25 Зіланд Фарма А/С Модифіковані міметики лізину
EP2074087A2 (de) 2006-12-21 2009-07-01 Wyeth Synthese von pyrrolidinverbindungen
FR2921257B1 (fr) 2007-09-21 2009-11-06 Exsymol Sa Utilisation topique de derives thiazolidines contre les consequences du stress oxydatif de la peau
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
KR101496795B1 (ko) 2010-05-28 2015-03-02 아지노모토 가부시키가이샤 시스테인 유도체
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
JP5979155B2 (ja) * 2011-11-30 2016-08-24 味の素株式会社 システイン誘導体およびアルコールを含有する化粧料
EP2786741B1 (de) * 2011-11-30 2018-12-26 Ajinomoto Co., Inc. Bleichendes kosmetikum
WO2013081192A1 (ja) * 2011-11-30 2013-06-06 味の素株式会社 システイン誘導体および界面活性剤を含有する化粧料
JP5994789B2 (ja) * 2011-11-30 2016-09-21 味の素株式会社 シワ防止化粧料
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2014203176A1 (en) * 2013-06-19 2014-12-24 Kop Research Centre Pvt Ltd Water soluble compositions for treating hair loss & promoting hair growth
EP3145489A1 (de) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natürliche kombinierte hormonersatzformulierungen und therapien
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CN110709096B (zh) 2017-05-05 2023-10-31 泽兰德制药公司 细胞间隙连接通讯调节剂及其在糖尿病性眼病治疗中的应用
EP3727314B1 (de) 2017-12-20 2021-10-13 Unilever IP Holdings B.V. Deodorierende zusammensetzungen

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806525A (en) * 1987-06-18 1989-02-21 Mavi S.R.L. Formulation comprising gelatin and glycine for treating the dryness of skin
US5208249A (en) * 1992-08-20 1993-05-04 Clintec Nutrition Co. Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate
AU7596994A (en) * 1993-11-01 1995-05-18 Free Radical Sciences, Inc. Methods and compositions for retarding the aging process
US5681852A (en) * 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
JPH11508154A (ja) * 1995-05-26 1999-07-21 ユニリーバー・ナームローゼ・ベンノートシヤープ 皮膚のためのトリートメント処理
FR2742658B1 (fr) * 1995-12-22 1998-01-30 Oreal Utilisation de la procysteine comme agent depigmentant
US6063389A (en) * 1995-12-22 2000-05-16 L'oreal Composition for depigmenting or bleaching mammalian skin containing L-2-oxothiazolidine-4-carboxylic acid and a polyol
FR2742750B1 (fr) * 1995-12-22 1998-01-30 Oreal Nouveaux derives de l'acide l-2-oxothiazolidine 4-carboxylique et leur utilisation pour le soin de la peau
FR2751331A1 (fr) * 1996-07-18 1998-01-23 Oreal Nouveau derive de l'acide kojique et son utilisation comme agent depigmentant
DE852949T1 (de) * 1997-03-31 1998-11-19 Shiseido Co Ltd Verwendung von Alpha-Aminosäuren zur Förderung des desmosomalen Abbaues oder der Abschuppung der Hornschicht
FR2767833B1 (fr) * 1997-08-29 2001-03-02 Oreal Polypeptide isole de l'epiderme et son utilisation
FR2773323B1 (fr) * 1998-01-05 2000-02-11 Oreal Composition contenant une association de procysteine et de polyol
US5989527A (en) * 1998-01-26 1999-11-23 Inolex Investment Corporation Compositions and methods for improving the performance of chemical exfoliating agents, sunless tanning agents, skin lightening agents and insect repellents
FR2790953B1 (fr) * 1999-03-19 2002-08-09 Oreal Composition a phase aqueuse continue renfermant de l'acide l-2-oxothiazolidine 4-carboxylique

Also Published As

Publication number Publication date
US20070232574A1 (en) 2007-10-04
FR2816838B1 (fr) 2004-12-03
AU2002223058A1 (en) 2002-05-27
DE60143906D1 (de) 2011-03-03
JP4072433B2 (ja) 2008-04-09
JP2004517063A (ja) 2004-06-10
ES2360204T3 (es) 2011-06-01
WO2002039976A1 (fr) 2002-05-23
EP1337234B1 (de) 2011-01-19
US20040006115A1 (en) 2004-01-08
US20100179200A1 (en) 2010-07-15
FR2816838A1 (fr) 2002-05-24
EP1337234A1 (de) 2003-08-27

Similar Documents

Publication Publication Date Title
ATE495736T1 (de) Verwendung von derivaten der 2-oxothiazolidin-4- corbonsäure als prä-abschuppungsmittel
DE60315146D1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
EE9900217A (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
DK1686119T3 (da) Pyrimidin-5-on-derivater som LDL-PLA2 inhibitorer
BR0207278A (pt) Derivados de ftalazinona-piperidina como inibidores de pde4
BR9806752A (pt) Ftalazinonas.
DE69911210D1 (de) Verwendung von piperin und derivate davon zur behandlung von hautpigmentierungstörungen und hautkrebs
DE60028010D1 (de) Verminderung des haarwuchses
DE60121461D1 (de) Kondensierte pyridoindolderivate
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
NO20002218L (no) Anvendelse av mirtazepin for behandling av søvnapne
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
ATE521331T1 (de) Verwendung von bis-resorcinyltriazinderivaten in kosmetischen oder dermatologischen zubereitungen
DE60041001D1 (de) Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien
DE60112148D1 (de) Verwendung von (Per)fluoroetherverbindungen als Zusatzstoffe in Formulierungen zur Holzbehandlung
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
BR0110490B1 (pt) agentes de tingimento contendo derivados de n-heteroarilmetil-m-fenilenodiamina para fibras de queratina bem como novos derivados de n-heteroarilmetil-m-fenilenodiamina.
DK1115375T3 (da) Anvendelse af mindst ét 10-hydroxy-2-decensyrederivat i et præparat til at fremme hudafstödning
CY1106472T1 (el) Η χρηση των παραγωγων υδροξυπυριδονης στην επουλωση πληγων
DE502004011187D1 (de) M-diaminobenzole und deren säureaddukte sowie deren verwendung in färbemitteln
ATE247649T1 (de) Disubstituierte biphenyloxazoline
ATE389014T1 (de) Phosphorylierte glyoxalase i und deren verwendung
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
DE50003481D1 (de) Verwendung von schmutzablösenden formulierungen zur behandlung von oberflächen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties